Error loading player: No playable sources found

  To view this video content in its entirety, click on the "Access Content" button and login to your account.

If you do not have an account, register for free.

Please note that the account you create here is different than your Keystone Symposia account at www.keystonesymposia.org used to register for our multi-day conferences and is uniquely for viewing our virtual content.


A novel conserved-region T-cell mosaic vaccine with very globale coverage of HIV-1 variants is recognized by protective responses in chronic untreated infection

Free
Standard Price
This product is also available as part of the following products:

Keystone Symposia SciTalks:

A novel conserved-region T-cell mosaic vaccine with very globale coverage of HIV-1 variants is recognized by protective responses in chronic untreated infection


Recorded: March 20 - 24, 2016

Keystone Symposia meeting: HIV Vaccines [X8]

Location: Resort at Squaw Creek, Olympic Valley, CA


c4e08c8e8923613e37046f6b05573d3a.png


___

Copyright Keystone Symposia, 2017. All rights reserved.

About Keystone Symposia:

Keystone Symposia is a 501(c)(3) nonprofit organization founded in 1972 that convenes 50-60 open, international scientific research conferences each year across the full range of the life sciences – from cardiovascular disease to immunology to neurobiology. The conferences accelerate life science discovery by bringing together and fostering collaboration among the world’s leading and next generation of research scientists.

Website: www.keystonesymposia.org



Speaker

Speaker Image for Tomas Hanke
University of Oxford

Related Products

Thumbnail for Deciphering the molecular basis of unusually high neutralization resistance in a tier 3 HIV-1 strain
Deciphering the molecular basis of unusually high neutralization resistance in a tier 3 HIV-1 strain
DECIPHERING THE MOLECULAR BASIS OF UNUSUALLY HIGH NEUTRALIZATION RESISTANCE IN A TIER 3 HIV-1 STRAIN
Thumbnail for Combined use of live-attenuated and inactivated influenza vaccines to enhance heterosubtypic protection
Combined use of live-attenuated and inactivated influenza vaccines to enhance heterosubtypic protection
The limited protection of current commercial vaccines necessitates the investigation of novel vaccine strategies for unpredictable outbreaks…
Thumbnail for Advancing Towards A General Solution for Coronavirus Vaccines
Advancing Towards A General Solution for Coronavirus Vaccines
Coronaviruses (CoVs) thrive in animal reservoirs and represent a constant threat to human health as most recently exemplified the 2012 emergence of MERS-CoV, which is responsible for 2229 reported cases and 791 deaths worldwide…
Thumbnail for Advancing Towards a General Solution for Coronavirus Vaccines [POSTER PRESENTATION]

Copyright © 2025 Keystone Symposia
Powered by Conexiant DXP
Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.